Norman LaFrance's most recent trade in Plus Therapeutics Inc was a trade of 24,073 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 22, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Plus Therapeutics Inc | Norman LaFrance | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 24,073 | 24,073 | - | - | Stock Option (Right to Buy) | |
| Plus Therapeutics Inc | Norman LaFrance | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 74,981 | 74,981 | - | - | Stock Option (Right to Buy) |